Hiro Nakao

Ostéomyélite afébrile se manifestant comme une pseudoparalysie chez un nourrisson

Taro Higuchi, Hiro Nakao, Yoshitsugu Fukuda

Teaching NeuroImage: Progressive Intracranial Calcifications and Pulmonary Disease in an Infant, Consistent With Type I Interferonopathy

Tsuyoshi Aihara, Takashi Ishikawa, Hiro Nakao, Yoshiyuki Tsutsumi et autres

A 2-month-old infant developed respiratory failure due to pneumocystis, cytomegalovirus, and Aspergillus pneumonia, suggesting immunodeficiency.Although screening head CT at 3 months for disseminated infection was normal, motor delay without focal neurologic deficits prompted repeat CT at 10 months, revealing progressive calcifications in …

jp (code pays fourni par la source)

Pontocerebellar hypoplasia type 7 with multiple congenital anomalies and progressive neurological course: a case report

Mei Kamidani, Itaru Hayakawa, Ai Ito-Shinjo, Hiro Nakao et autres

Introduction Pontocerebellar hypoplasia type 7 (PCH7) is an ultrarare autosomal recessive neurodevelopmental disorder caused by biallelic loss-of-function variants in TOE1 . Typical manifestations include pontocerebellar hypoplasia and 46,XY disorders of sex development. However, because of its rarity, the longitudinal clinical course and …

jp (code pays fourni par la source)

Afebrile osteomyelitis presenting as pseudoparalysis in an infant

Taro Higuchi, Hiro Nakao, Yoshitsugu Fukuda

jp (code pays fourni par la source)

Biphasic stridor in an early infant

Naho Konno, Taro Higuchi, Hiro Nakao, Kensuke Shoji et autres

The authors declare no conflicts of interest. Data sharing not applicable to this article as no datasets were generated or analysed during the current study.

jp (code pays fourni par la source)

An Adolescent With a Cervical Cyst Infection due to Bordetella holmesii

Natsuhiko Yamada, Tatsuki Ikuse, Ito Kato, Ai Niida et autres

The authors declare no conflicts of interest. Data sharing not applicable to this article as no datasets were generated or analysed during the current study. Table S1: Antibiotic susceptibility profile of Bordetella holmesii. Please note: The publisher is not responsible for the …

jp (code pays fourni par la source)

Unusual Midline Chest Wall Cellulitis in an Infant Without Trauma or Skin Barrier Disruption

Morihide Kanawa, Hiro Nakao, Tatsuki Ikuse, Mitsuru Kubota et autres

Cellulitis in children usually develops on the extremities or face following minor trauma or skin barrier disruption, and involvement of the trunk is uncommon. We report a one-year-old previously healthy boy who presented with fever and a rapidly enlarging anterior chest wall …

jp (code pays fourni par la source)

Venographic Assistance in Peripherally Inserted Central Catheter Placement in a Pediatric Patient: A Case Report

Yusuke Tokuda, Hiro Nakao, Shintaro Morooka, Mitsuru Kubota

Peripherally inserted central catheters (PICCs) are commonly used in pediatric patients for long-term IV access because of their ease of insertion and lower risk of complications such as pneumothorax or hemothorax. However, difficulties may arise when advancing the catheter due to venous …

jp (code pays fourni par la source)

Infant with Seizures

Hiro Nakao

jp (code pays fourni par la source)

Trisomy 13 as a risk factor for pulmonary hypertension induced by diazoxide

Kazu Ishikawa, Hiro Nakao, Daisuke Shinjo, Mitsuru Kubota et autres

Introduction: Diazoxide has been used globally for hyperinsulinemic hypoglycemia. However, serious adverse drug reactions, such as pulmonary hypertension (PH), are major concerns. This study aimed to determine the baseline risk of diazoxide administration leading to the development of PH. Materials and Methods: …

jp (code pays fourni par la source)

Effect of additional intravenous immunoglobulin for infliximab-refractory Kawasaki disease: a cohort study

Hiro Nakao, Hiroshi Masuda, Hiroshi Ono, Mitsuru Kubota et autres

BACKGROUND: Infliximab (IFX) is a reliable choice of treatment for intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD) patients. Nationwide surveys in Japan demonstrated that additional treatment was still required for 20-30% of patients after IFX infusion. Additional IVIG was selected for 70% as …

jp (code pays fourni par la source)

Effect of additional intravenous immunoglobulin for infliximab-refractory Kawasaki disease: a cohort study

Sadashi Hatano, Hiro Nakao, Hiroshi Masuda, Hiroshi Ono et autres

jp (code pays fourni par la source)